Regulatory Roles and Clinical Implications of Non-Coding RNAs in Cardiovascular Issues Associated with SARS-CoV-2 Infection
Background
The COVID-19 pandemic has revealed profound cardiovascular complications associated with SARS-CoV-2 infection, including acute cardiac injury and long-term sequelae. Understanding the molecular mechanisms, particularly the role of non-coding RNAs, is crucial.
Data Highlights
No specific numerical data or trial data provided in the source material.
Key Findings
Over 20%-25% of hospitalized COVID-19 patients exhibit myocardial injury, linked to elevated cardiac troponin levels.
Cardiovascular complications include acute coronary syndromes, myocarditis, arrhythmias, and heart failure.
Non-coding RNAs (miRNAs, lncRNAs, circRNAs) are involved in the regulation of apoptosis, metabolic reprogramming, and cell communication during SARS-CoV-2 infection.
The dysregulated immune response and cytokine storm contribute significantly to cardiovascular damage in COVID-19.
Host ncRNAs may be exploited by the virus to facilitate replication and evade immune responses.
Clinical Implications
Identifying ncRNAs as potential biomarkers could enhance diagnostic and therapeutic strategies in clinical practice.
Conclusion
The interplay between SARS-CoV-2 infection and cardiovascular health underscores the importance of understanding ncRNAs in this context.
